Skip to main content

28.03.2024 | Original Article

Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV

verfasst von: Betsy D. Kennard, Larry K. Brown, Kristin Baltrusaitis, Miriam Chernoff, Graham J. Emslie, Jessica Jones, Sarah Buisson, Jaime Deville, Megan Wilkins, Amber Bunch, Chivon McMullen Jackson, Christy Beneri, David E. Shapiro, and IMPAACT 2002 Team

Erschienen in: Cognitive Therapy and Research

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This is a secondary analysis of a multi-site, cluster (site) randomized trial of the efficacy of a combined Health and Wellness Cognitive Behavior Therapy (H&W CBT) and medication management approach for depression in youth with HIV (YWH) compared to standard care. In this study, we explored the association between H&W CBT factors and depression outcomes after 24 weeks of treatment to discover treatment elements associated with symptom reduction.

Methods

Participants (12–24 years of age) were YWH in the United States (US) diagnosed with moderate to severe depression [Quick Inventory of Depressive Symptomatology (QIDS), Clinician-Rated score ≥ 11]. Thirteen US sites were randomly assigned to either the combination treatment approach or standard care. For site-level analyses, site-specific summary scores were used to account for the within site correlation.

Results (all scores are site-level)

The number of depressive symptoms [QIDS-Self Reported (QIDS-SR) score] after 24 weeks of H&W CBT was significantly negatively correlated with the mean total session duration (ρ = − 0.94), the total homework assigned (ρ = − 0.83), the total number of practice modules used (ρ = − 0.83), and the mean total booster sessions given (ρ = − 0.82).

Conclusions

Specific elements of the H&W CBT (e.g., dose, assignment of homework, greater skills practice, and use of booster sessions) were associated with improvement of depression outcomes in YWH. A focus on these elements in treatment may improve symptom reduction for YWH with depression.
Literatur
Zurück zum Zitat Bernstein, I. H., JohnRush, A., Trivedi, M. H., Hughes, C. W., Macleod, L., Witte, B. P., Jain, S., Mayes, T. L., & Emslie, G. J. (2010). Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents. International Journal of Methods in Psychiatric Research, 19(4), 185–194. https://doi.org/10.1002/mpr.321CrossRefPubMedPubMedCentral Bernstein, I. H., JohnRush, A., Trivedi, M. H., Hughes, C. W., Macleod, L., Witte, B. P., Jain, S., Mayes, T. L., & Emslie, G. J. (2010). Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents. International Journal of Methods in Psychiatric Research, 19(4), 185–194. https://​doi.​org/​10.​1002/​mpr.​321CrossRefPubMedPubMedCentral
Zurück zum Zitat Brown, L. K., Chernoff, M., Kennard, B. D., Emslie, G. J., Lypen, K., Buisson, S., Weinberg, A., Whiteley, L. B., Traite, S., Krotje, C., Harriff, L., Townley, E., Bunch, A., Purswani, M., Shaw, R., Spector, S. A., Agwu, A., Shapiro, D. E., IMPAACT 2002 team. (2021). Site-randomized controlled trial of a combined cognitive behavioral therapy and a medication management algorithm for treatment of depression among youth living with HIV in the United States. Journal of Acquired Immune Deficiency Syndromes, 88(5), 497–505. https://doi.org/10.1097/QAI.0000000000002790CrossRefPubMed Brown, L. K., Chernoff, M., Kennard, B. D., Emslie, G. J., Lypen, K., Buisson, S., Weinberg, A., Whiteley, L. B., Traite, S., Krotje, C., Harriff, L., Townley, E., Bunch, A., Purswani, M., Shaw, R., Spector, S. A., Agwu, A., Shapiro, D. E., IMPAACT 2002 team. (2021). Site-randomized controlled trial of a combined cognitive behavioral therapy and a medication management algorithm for treatment of depression among youth living with HIV in the United States. Journal of Acquired Immune Deficiency Syndromes, 88(5), 497–505. https://​doi.​org/​10.​1097/​QAI.​0000000000002790​CrossRefPubMed
Zurück zum Zitat Donenberg, G. R., Fitts, J., Ingabire, C., Nsanzimana, S., Fabri, M., Emerson, E., Remera, E., Manzi, O., Bray, B., & Cohen, M. H. (2022). Results of the Kigali Imbereheza Project: A 2-Arm individually randomized trial of TI-CBT enhanced to address ART adherence and mental health for Rwandan youth living with HIV. Journal of Acquired Immune Deficiency Syndromes, 90(1), 69–78. https://doi.org/10.1097/QAI.0000000000002911CrossRefPubMed Donenberg, G. R., Fitts, J., Ingabire, C., Nsanzimana, S., Fabri, M., Emerson, E., Remera, E., Manzi, O., Bray, B., & Cohen, M. H. (2022). Results of the Kigali Imbereheza Project: A 2-Arm individually randomized trial of TI-CBT enhanced to address ART adherence and mental health for Rwandan youth living with HIV. Journal of Acquired Immune Deficiency Syndromes, 90(1), 69–78. https://​doi.​org/​10.​1097/​QAI.​0000000000002911​CrossRefPubMed
Zurück zum Zitat Emslie, G. J., Brister, T., Chapman, M., Dulcan, M. K., Galanter, C. A., Jones, J. M., Kennard, B., Pavlon-Blum, J., Petti, T. A., Robb, A. S., & Wilens, T. E. (2019). Depression Parents’ Medication Guide. American Academy of Child & Adolescent Psychiatry. Emslie, G. J., Brister, T., Chapman, M., Dulcan, M. K., Galanter, C. A., Jones, J. M., Kennard, B., Pavlon-Blum, J., Petti, T. A., Robb, A. S., & Wilens, T. E. (2019). Depression Parents’ Medication Guide. American Academy of Child & Adolescent Psychiatry.
Zurück zum Zitat Glasgow, R. E., Lichtenstein, E., & Marcus, A. C. (2003). Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. American Journal of Public Health, 93, 1261–1267.CrossRefPubMedPubMedCentral Glasgow, R. E., Lichtenstein, E., & Marcus, A. C. (2003). Why don’t we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. American Journal of Public Health, 93, 1261–1267.CrossRefPubMedPubMedCentral
Zurück zum Zitat Kennard, B. D., Brown, L. T., Hawkins, L., Risi, A., Radcliffe, J., Emslie, G. J., Mayes, T. L., King, J. D., Foxwell, A. A., Buyukdura, J., Bethel, J., Naar-King, S., Xu, J., Lee, S. S., Garvie, P., London, C., Tanney, M., & Thornton, S. (2014). Development and implementation of health and wellness CBT for individuals with depression and HIV. Cognitive and Behavioral Practice, 21(2), 237–246. https://doi.org/10.1016/j.cbpra.2013.07.003CrossRefPubMedPubMedCentral Kennard, B. D., Brown, L. T., Hawkins, L., Risi, A., Radcliffe, J., Emslie, G. J., Mayes, T. L., King, J. D., Foxwell, A. A., Buyukdura, J., Bethel, J., Naar-King, S., Xu, J., Lee, S. S., Garvie, P., London, C., Tanney, M., & Thornton, S. (2014). Development and implementation of health and wellness CBT for individuals with depression and HIV. Cognitive and Behavioral Practice, 21(2), 237–246. https://​doi.​org/​10.​1016/​j.​cbpra.​2013.​07.​003CrossRefPubMedPubMedCentral
Zurück zum Zitat Kennard, B. D., Clarke, G. N., RobinWeersing, V., Asarnow, J. R., Shamseddeen, W., Porta, G., Berk, M., Hughes, J. L., Spirito, A., Emslie, G. J., Keller, M. B., Wagner, K. D., & Brent, D. A. (2009). Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: Preliminary findings. Journal of Consulting and Clinical Psychology, 77(6), 1033–1041. https://doi.org/10.1037/a0017411CrossRefPubMedPubMedCentral Kennard, B. D., Clarke, G. N., RobinWeersing, V., Asarnow, J. R., Shamseddeen, W., Porta, G., Berk, M., Hughes, J. L., Spirito, A., Emslie, G. J., Keller, M. B., Wagner, K. D., & Brent, D. A. (2009). Effective components of TORDIA cognitive-behavioral therapy for adolescent depression: Preliminary findings. Journal of Consulting and Clinical Psychology, 77(6), 1033–1041. https://​doi.​org/​10.​1037/​a0017411CrossRefPubMedPubMedCentral
Zurück zum Zitat Zuckerbrot, R. A., Cheung, A., Jensen, P. S., Stein, R. E. K., Laraque, D., GLAD-PC STEERING GROUP. (2018). Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice preparation, identification, assessment, and initial management. Pediatrics, 141(3), e20174081. https://doi.org/10.1542/peds.2017-4081CrossRefPubMed Zuckerbrot, R. A., Cheung, A., Jensen, P. S., Stein, R. E. K., Laraque, D., GLAD-PC STEERING GROUP. (2018). Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice preparation, identification, assessment, and initial management. Pediatrics, 141(3), e20174081. https://​doi.​org/​10.​1542/​peds.​2017-4081CrossRefPubMed
Metadaten
Titel
Cognitive Behavioral Therapy Factors Related to Outcomes in Depression Among Youth with HIV
verfasst von
Betsy D. Kennard
Larry K. Brown
Kristin Baltrusaitis
Miriam Chernoff
Graham J. Emslie
Jessica Jones
Sarah Buisson
Jaime Deville
Megan Wilkins
Amber Bunch
Chivon McMullen Jackson
Christy Beneri
David E. Shapiro
and IMPAACT 2002 Team
Publikationsdatum
28.03.2024
Verlag
Springer US
Erschienen in
Cognitive Therapy and Research
Print ISSN: 0147-5916
Elektronische ISSN: 1573-2819
DOI
https://doi.org/10.1007/s10608-024-10474-0

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.